Cargando…
Mmp13 deletion in mesenchymal cells increases bone mass and may attenuate the cortical bone loss caused by estrogen deficiency
The protective effect of estrogens against cortical bone loss is mediated via direct actions on mesenchymal cells, but functional evidence for the mediators of these effects has only recently begun to emerge. We report that the matrix metalloproteinase 13 (MMP13) is the highest up-regulated gene in...
Autores principales: | Ponte, Filipa, Kim, Ha-Neui, Warren, Aaron, Iyer, Srividhya, Han, Li, Mannen, Erin, Gomez-Acevedo, Horacio, Nookaew, Intawat, Almeida, Maria, Manolagas, Stavros C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205908/ https://www.ncbi.nlm.nih.gov/pubmed/35715555 http://dx.doi.org/10.1038/s41598-022-14470-w |
Ejemplares similares
-
Estrogens decrease osteoclast number by attenuating mitochondria oxidative phosphorylation and ATP production in early osteoclast precursors
por: Kim, Ha-Neui, et al.
Publicado: (2020) -
Mitochondrial Sirt3 contributes to the bone loss caused by aging or estrogen deficiency
por: Ling, Wen, et al.
Publicado: (2021) -
Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
por: Palmieri, Michela, et al.
Publicado: (2023) -
A decrease in NAD(+) contributes to the loss of osteoprogenitors and bone mass with aging
por: Kim, Ha-Neui, et al.
Publicado: (2021) -
Elimination of senescent osteoclast progenitors has no effect on the age‐associated loss of bone mass in mice
por: Kim, Ha‐Neui, et al.
Publicado: (2019)